MAPT and Alzheimer disease: Furthermore, analyzes of the relationship between insulin resistance and AD biomarkers during the asymptomatic, preclinical stage in at-risk populations revealed that insulin resistance was associated with higher CSF tau, p-tau (Willette et al., 2015) and Aβ42 (Hoscheidt et al., 2016).